Aytu Biopharma Inc reports results for the quarter ended in March - Earnings Summary

Aytu Biopharma

17/05/2022 16:23

* Aytu Biopharma Inc  AYTU.OQ  reported a quarterly adjusted
loss
of $1.79​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 41 cents per
share.
    * Revenue rose 79.5% to $24.20 million from a year ago; 
analysts
expected $24.80 million. 
    * Aytu Biopharma Inc's reported EPS for the quarter was a
loss of
$1.79​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Aytu Biopharma Inc shares had fallen by 55.0% this
quarter and
lost 64.0% so far this year.
    * The company reported a quarterly loss of $53.07 million.
    * Wall Street's median 12-month price target for Aytu
Biopharma
Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 17 at 03:23 p.m.  ​All
figures in US dollars unless otherwise stated